Bradley J Phd Bolzon's Net Worth

$27 Million

Estimate Recalculated Jun 10, 2025 09:31PM EST

Who is Bradley J Phd Bolzon

Bradley J Phd Bolzon has an estimated net worth of $27 Million. This is based on reported shares across multiple companies, which include Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, HELICOS BIOSCIENCES CORP, Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, Monte Rosa Therapeutics, Inc., CRISPR Therapeutics AG, Black Diamond Therapeutics, Inc., NOVACEA INC, and PHASERX, INC..

SEC CIK

Bradley J Phd Bolzon's CIK is 0001354345

Past Insider Trading and Trends

2020 was Bradley J Phd Bolzon's most active year for acquiring shares with 20 total transactions. Bradley J Phd Bolzon's most active month to acquire stocks was the month of May. 2021 was Bradley J Phd Bolzon's most active year for disposing of shares, totalling 27 transactions. Bradley J Phd Bolzon's most active month to dispose stocks was the month of May. 2017 saw Bradley J Phd Bolzon paying a total of $0.00 for 55,447 shares, this is the most they've acquired in one year. In 2020 Bradley J Phd Bolzon cashed out on 340,648 shares for a total of $5,869,624.72, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alexza Pharmaceuticals Inc.

Investor
Updated Mar 14, 2006
Form 4
-80.38%
-8.95M
Mar 14, 2006
2.18M
Options
Mar 13
Form 3
Mar 08, 2006
Showing 2 results

Flexion Therapeutics Inc

Investor
Updated Jun 10, 2016
Form 4
25.35%
714.28K
$14.00
$10.00M
Jun 10, 2016
3.92M
Purchase
Jun 08
Form 4
$17.61
$39.62K
Sep 12, 2014
9.00K
Options
Sep 10
Form 4
9.00K
Mar 04, 2014
9.00K
Grant
Mar 03
Form 4
-85.94%
-19.61M
$13.00
Feb 20, 2014
3.21M
Buy-Options
Feb 18
Form 3
Feb 11, 2014
105.78K
Showing 5 results

Monte Rosa Therapeutics, Inc.

Investor
Updated Jun 30, 2021
Form 4
-70.48%
-21.24M
$19.00
Jun 30, 2021
8.90M
Buy-Options
Jun 28
Form 4
176.82%
6.32M
$2.32
$15.15M
Jun 25, 2021
9.90M
Grant
Feb 24 - Jun 23
Form 3
Jun 23, 2021
283.25K
Showing 3 results

CRISPR Therapeutics AG

Investor
Updated Jun 10, 2022
Form 4
12.00K
Jun 10, 2022
12.00K
Grant
Jun 09
Form 4
-6.30%
-10.00K
$126.43
-$1.26M
Jul 21, 2021
498.56K
Sale
ScheduledJul 19
Form 4
-67.01%
-1.04M
$149.49
-$7.11M
Jun 30, 2021
510.25K
Sale
ScheduledJun 28 - Jun 29
Form 4
-16.05%
-30.38K
$152.48
-$4.63M
Jun 30, 2021
158.83K
Sale
ScheduledJun 28
Form 4
-32.92%
-10.00K
$126.61
-$1.27M
Jun 15, 2021
1.58M
Sale
ScheduledJun 11
Form 4
10.00K
Jun 14, 2021
10.00K
Grant
Jun 10
Form 4
-50.00%
-30.37K
$132.37
-$4.02M
Mar 24, 2021
1.59M
Sale
ScheduledMar 22
Form 4
-24.21%
-264.88K
Mar 03, 2021
1.72M
Disposition
ScheduledMar 01
Form 4
-36.23%
-1.16M
$149.11
-$25.50M
Feb 23, 2021
2.04M
Sale
Feb 19
Form 4
-4.23%
-15.00K
$148.95
-$2.23M
Dec 18, 2020
3.04M
Sale
ScheduledDec 16
Form 4/A
-81.18%
-33.00K
$143.35
-$4.73M
Dec 17, 2020
3.06M
Sale
ScheduledDec 10
Form 4
-9.50%
-33.00K
$143.35
-$4.73M
Dec 14, 2020
3.06M
Sale
ScheduledDec 10
Form 4
-33.00%
-171.00K
$154.53
-$26.42M
Dec 09, 2020
3.09M
Sale
Dec 07
Form 4
-22.17%
-394.36K
Nov 02, 2020
3.26M
Disposition
ScheduledOct 29
Form 4
-15.06%
-315.49K
Sep 24, 2020
3.65M
Disposition
ScheduledSep 22
Form 4
-0.58%
-3.04K
$86.87
-$263.64K
Sep 22, 2020
3.97M
Sale
ScheduledSep 18
Form 4
-1.69%
-8.96K
$86.98
-$779.78K
Sep 18, 2020
3.97M
Sale
ScheduledSep 16
Form 4
-0.22%
-1.16K
$84.89
-$98.05K
Sep 16, 2020
3.98M
Sale
ScheduledSep 14
Form 4
-6.43%
-180.59K
$85.36
-$1.95M
Sep 11, 2020
3.98M
Sale
ScheduledSep 09 - Sep 10
Form 4
-50.00%
-60.00K
$58.87
-$4.04M
Sep 03, 2020
4.22M
Sale
Sep 01
Form 4
-3.48%
-20.00K
$82.39
-$1.65M
Jul 08, 2020
4.16M
Sale
ScheduledJul 06
Form 4
-3.37%
-20.00K
$73.93
-$1.48M
Jun 24, 2020
4.18M
Sale
ScheduledJun 22 - Jun 23
Form 4
15.00K
Jun 15, 2020
15.00K
Grant
Jun 11
Form 4
-6.58%
-42.00K
$67.41
-$2.83M
Nov 21, 2019
4.21M
Sale
ScheduledNov 19
Form 4
-60.44%
-21.00K
$51.89
-$1.09M
Nov 01, 2019
4.25M
Sale
ScheduledOct 30
Form 4
15.00K
Jun 13, 2019
15.00K
Grant
Jun 11
Form 4
30.00K
Jun 15, 2018
30.00K
Grant
Jun 15
Form 4
-6.43%
-44.00K
$57.99
-$2.55M
May 17, 2018
674.76K
Sale
May 15
Form 4
-4.47%
-128.95K
$50.76
-$6.50M
May 09, 2018
2.76M
Sale
ScheduledMay 07 - May 08
Form 4
-2.03%
-30.57K
$50.28
-$1.54M
May 02, 2018
1.52M
Sale
ScheduledApr 30
Form 4
-6.84%
-222.26K
$50.08
-$11.14M
Apr 30, 2018
3.03M
Sale
ScheduledApr 26 - Apr 27
Form 4
-1.30%
-22.84K
$50.90
-$1.16M
Apr 26, 2018
1.73M
Sale
ScheduledApr 24
Form 4
-12.64%
-585.73K
$50.83
-$5.17M
Apr 24, 2018
4.05M
Sale
ScheduledApr 20 - Apr 23
Form 4
-48.41%
-26.02K
$20.30
-$528.24K
Dec 27, 2017
27.72K
Sale
ScheduledDec 22
Form 4
-3.08%
-1.71K
$20.21
-$34.50K
Nov 28, 2017
53.74K
Sale
ScheduledNov 24 - Nov 27
Form 4
-32.53%
-2.25M
Sep 07, 2017
4.66M
Disposition
Sep 05
Form 4
30.00K
Jun 02, 2017
30.00K
Grant
May 31
Form 4
2.82%
191.00K
$14.00
Dec 23, 2016
7.65M
Purchase
Oct 18 - Oct 24
Form 3/A
Dec 23, 2016
923.66K
Form 4
30.00K
Oct 20, 2016
30.00K
Grant
Oct 18
Form 3
Oct 18, 2016
581.66K
Showing 41 results

Inogen Inc

Investor
Updated May 11, 2015
Form 4/A
-11.28%
-384.69K
$24.30
-$179.53K
May 11, 2015
3.03M
Sale
Nov 05 - Nov 07
Form 4
-35.10%
-735.77K
Jan 08, 2015
1.39M
Disposition
Jan 06 - Jan 07
Form 4
-100.00%
-7.95K
$30.98
-$246.16K
Jan 06, 2015
2.13M
Sale
Jan 05
Form 4/A
-18.22%
-478.05K
Jan 05, 2015
2.15M
Disposition
Dec 18
Form 4
-100.00%
-9.79K
$29.74
-$291.01K
Dec 29, 2014
2.14M
Sale
Dec 23
Form 4
-18.22%
-478.05K
Dec 22, 2014
2.15M
Disposition
Dec 18
Form 4
-41.03%
-28.23K
$24.80
-$699.25K
Nov 19, 2014
2.62M
Sale
Nov 17 - Nov 19
Form 4
-22.13%
-753.69K
$25.13
-$237.09K
Nov 14, 2014
2.65M
Sale
Nov 12 - Nov 14
Form 4
-100.00%
-8.64K
$24.53
-$211.69K
Nov 12, 2014
3.41M
Sale
Nov 10
Form 4
4.31%
4.44K
$24.30
-$179.53K
Nov 07, 2014
3.41M
Acquisition
Nov 05 - Nov 07
Form 4
Oct 28, 2014
3.41M
Form 4
Oct 14, 2014
3.41M
Form 4
-77.05%
-51.70K
Oct 09, 2014
3.41M
Disposition
Oct 07
Showing 13 results

SECOND SIGHT MEDICAL PRODUCTS INC

Investor
Updated Dec 02, 2014
Form 3/A
Dec 02, 2014
4.49M
Form 3
Nov 18, 2014
4.49M
Showing 2 results

Black Diamond Therapeutics, Inc.

Investor
Updated Jun 22, 2021
Form 4
15.00K
Jun 22, 2021
15.00K
Grant
Jun 18
Form 4
-2.40%
-20.77K
Dec 16, 2020
6.45M
Disposition
ScheduledDec 14
Form 4
-8.26%
-433.30K
$33.15
-$344.51K
Dec 01, 2020
6.47M
Sale
ScheduledNov 27 - Nov 30
Form 4
-9.89%
-757.98K
Nov 25, 2020
6.91M
Disposition
Nov 23
Form 4
-2.20%
-130.02K
$33.01
-$4.29M
Nov 23, 2020
7.66M
Sale
ScheduledNov 19
Form 4
-0.04%
-4.73K
$33.07
-$156.35K
Nov 19, 2020
13.71M
Sale
ScheduledNov 17 - Nov 18
Form 4
-0.04%
-4.70K
$33.39
-$158.59K
Nov 17, 2020
13.72M
Sale
ScheduledNov 13 - Nov 16
Form 4
-7.00%
-960.14K
$34.15
-$532.64K
Nov 13, 2020
12.76M
Sale
ScheduledNov 11 - Nov 12
Form 4
-0.30%
-39.58K
$34.28
-$1.35M
Nov 12, 2020
15.41M
Sale
ScheduledNov 10 - Nov 11
Form 4
-0.07%
-9.40K
$33.10
-$310.95K
Nov 10, 2020
15.48M
Sale
ScheduledNov 06 - Nov 09
Form 4
-0.08%
-11.35K
$33.15
-$376.13K
Nov 06, 2020
15.50M
Sale
ScheduledNov 04 - Nov 05
Form 4
-0.07%
-8.90K
$33.17
-$296.29K
Oct 28, 2020
15.52M
Sale
ScheduledOct 26 - Oct 27
Form 4
-0.08%
-15.75K
$33.34
-$526.53K
Oct 20, 2020
22.25M
Sale
ScheduledOct 15 - Oct 19
Form 4
-0.13%
-17.24K
$33.24
-$574.02K
Oct 15, 2020
15.57M
Sale
ScheduledOct 13 - Oct 14
Form 4
-0.11%
-22.63K
$33.42
-$757.92K
Oct 13, 2020
22.34M
Sale
ScheduledOct 08 - Oct 12
Form 4
-1.95%
-334.06K
$33.41
-$1.54M
Oct 08, 2020
16.75M
Sale
ScheduledOct 06 - Oct 07
Form 4
-7.29%
-725.44K
Sep 21, 2020
9.22M
Disposition
ScheduledSep 17
Form 4
-4.59%
-298.28K
Aug 20, 2020
9.95M
Disposition
Aug 18
Form 4
-4.39%
-298.28K
Aug 14, 2020
10.24M
Disposition
ScheduledAug 12
Form 4
-0.09%
-13.79K
$33.06
-$455.99K
Aug 12, 2020
18.47M
Sale
ScheduledAug 10 - Aug 11
Form 4
-8.04%
-327.73K
Jul 29, 2020
10.56M
Disposition
ScheduledJul 27
Form 4
-35.35%
-18.57M
$19.00
$15.50M
Feb 05, 2020
33.98M
Buy-Options
Feb 03
Form 3
Jan 29, 2020
331.59K
Showing 23 results

NOVACEA INC

Investor
Updated May 15, 2006
Form 4
12.52%
230.77K
May 15, 2006
2.07M
Purchase
May 15
Form 3
May 09, 2006
Showing 2 results

PHASERX, INC.

Investor
Updated May 24, 2016
Form 4
21.36%
341.96K
$2.51
$3.00M
May 24, 2016
1.94M
Purchase
May 23
Form 3/A
May 24, 2016
1.60M
Form 3
May 17, 2016
1.54M
Showing 3 results

HELICOS BIOSCIENCES CORP

Investor
Updated Sep 21, 2009
Form 4
2.61%
403.75K
$1.33
$638.33K
Sep 21, 2009
15.90M
Purchase
Sep 18
Form 4
645.97%
13.79M
Dec 29, 2008
15.93M
Purchase
Dec 23
Form 4
-76.56%
-6.97M
$9.00
$1.00M
Jun 01, 2007
2.14M
Buy-Options
May 30
Form 3
May 24, 2007
Showing 4 results